ReachRxResearch
Home
Research
Sign Up
Priming of CD8+ T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration
Back to Research Hub
  1. Home
  2. Research Hub
  3. Priming of CD8+ T cells by peripheral de…

Priming of CD8+ T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration

Nature Neuroscience·September 3Open Access
NeurosciencesPractice changingAlzheimer'S DiseaseTauopathyPreclinical Animal StudyDendritic Cell BiologyT Cell ImmunologyAdult

Summary

View source

What was studied

This study examined how peripheral conventional type 1 dendritic cells (cDC1s) prime CD8+ T cells to infiltrate the brain and drive tau-mediated neurodegeneration, using tauopathy mouse models lacking cDC1s or antigen cross-presentation.

Key findings

Tauopathy mice deficient in cDC1s or antigen cross-presentation were protected from neurodegeneration, showing reduced brain CD8+ T cell infiltration, decreased glial activation, and limited CD8+ T cell clonal expansion — consistent with impaired peripheral priming. Brain-derived antigens were detected in secondary lymphoid tissues, pointing to those as the site of T cell activation.

Study limitations

Findings are based on mouse tauopathy models, which may not fully replicate human Alzheimer's disease or primary tauopathies. The study does not identify the specific tau-derived antigens presented by cDC1s. Causal directionality in human disease remains to be established.

Clinical implications

The cDC1-dependent peripheral priming pathway is a potential therapeutic target to limit CD8+ T cell-driven neurodegeneration in tauopathies. Strategies that disrupt dendritic cell cross-presentation or CD8+ T cell trafficking could be explored in Alzheimer's disease and related conditions.

Caveats

  • No human subjects were studied; all mechanistic findings are from mouse tauopathy models — clinical translation is speculative at this stage.
  • Sample size (N) is not reported in the abstract or available full text excerpt; the sample_size tag has been omitted.
  • Study design label 'Preclinical Animal Study' was assigned based on mouse model descriptions; the paper does not explicitly state this label.
Show all 4
  • The 'practice_changing' impact flag reflects the novelty of the cDC1 peripheral priming mechanism, but clinical applicability requires future human validation.

Related Questions

Explore related topics

What is the role of CD8+ T cells in Alzheimer's disease and tau pathology?How do conventional type 1 dendritic cells drive neuroinflammation in tauopathies?Are there therapies targeting T cell infiltration in Alzheimer's disease or neurodegeneration?

Publication Details

Year
2026
Journal
Nature Neuroscience
Source
View article
Keep scrolling
More content below.
Up Next